More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

Cardiologists and vascular surgeons were previously told they could still use the device if necessary. Now, however, the message is that they should return the product to the manufacturer.

In addition to launching Heartflow Plaque Staging, the company also shared new data at SCCT2026 highlighting the importance of using total plaque volume assessments to diagnose and manage heart patients. 

Long-term TAVR outcomes were comparable. When tracking 30-day data, however, researchers found that hospital readmission was much less common for patients treated with regional anesthesia or moderate sedation.

Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.

Andy Morse, MD, the director of valvular and structural heart disease at Ascension Saint Thomas Hospital West in Nashville, leads a team that has performed more than 4,000 TAVR procedures. He spoke to Cardiovascular Business about recent findings on the long-term performance of the balloon-expandable SAPIEN 3™ platform.

Back in June, CMS proposed significant updates to its current TAVR policies. Three leading healthcare societies have now joined forces to share their own perspective on the potential updates. 

The new-look ELANA device from AMT Medical could simplify CABG procedures and help improve patient access to minimally invasive and robotic surgical techniques.

In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.